GIB
CGI Inc.
GIB's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over GIB overall, supported by stronger valuation and stronger modeled upside.
GIB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Healthy |
GIB's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
GIB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 14x | $81.81 | — |
| Cheap | 17x | $97.00 | +19% |
| Fair | 20x | $114 | +39% |
| Expensive | 22x | $127 | +55% |
Historical ranges are pointers, not guarantees.
GIB has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
GIB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect GIB's earnings to grow and its profitability to improve, with its revenue holding steady.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over GIB on the outlook, with more favorable revenue expectations.
GIB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $5.67 | +7.2% |
| Q1 2026 | $5.39 | +0.7% |
| Q4 2025 | $5.24 | -1.3% |
| Q3 2025 | $5.16 | +0.4% |
| Q2 2025 | $5.29 | +5% |
| Q1 2025 | $5.35 | +8.5% |
| Q4 2024 | $5.31 | +8.8% |
| Q3 2024 | $5.14 | +6.4% |
GIB earned $5.67 per share over the past year, up 7.2% from the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over GIB on earnings, with more consistent year-over-year improvement.
GIB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.9B | +2.5% |
| Q1 2026 | $2.9B | +3.3% |
| Q4 2025 | $2.9B | +7.7% |
| Q3 2025 | $2.8B | +9.7% |
| Q2 2025 | $2.9B | +11% |
| Q1 2025 | $2.8B | +7.6% |
| Q4 2024 | $2.7B | +5.1% |
| Q3 2024 | $2.6B | +4.4% |
GIB's revenue has grown year over year for 20 quarters in a row: $2.9B last quarter, up 2.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 16% | 0 points |
| Q1 2026 | 17% | +0.1 points |
| Q4 2025 | 16% | -0.1 points |
| Q3 2025 | 33% | +17 points |
| Q2 2025 | 16% | -0.1 points |
| Q1 2025 | 17% | -0.3 points |
| Q4 2024 | 16% | +0.2 points |
| Q3 2024 | 16% | +16 points |
GIB's operating margin was 16% last quarter, about level with the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over GIB on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over GIB on profitability, with a higher operating margin.
GIB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $374.2M | +30% |
| Q1 2026 | $295.6M | +15% |
| Q4 2025 | $568.2M | +38% |
| Q3 2025 | $423M | +5.1% |
| Q2 2025 | $288.9M | -4.1% |
| Q1 2025 | $257.5M | -14% |
| Q4 2024 | $411.6M | +14% |
| Q3 2024 | $402.6M | +4.8% |
GIB's free cash flow has been positive every quarter for seven years: $1.7B over the past year, up 22% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over GIB on cash flow, with more consistent year-over-year improvement.
GIB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.1x | Healthy |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | 0.7x | Very low |
GIB's net debt is about 1.2 years of its operating earnings (EBITDA), up from 1.1 years a year ago.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has the edge over GIB on leverage, with a lower net debt burden relative to earnings.
GIB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.0 | Neutral |
| Stochastic | 91.1 | Overbought |
GIB's weekly RSI is 61 (neutral) and its Stochastic is 91 (overbought).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
GIB PE vs Technology Sector
| Metric | GIB | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 28x | 48% below |
| PE % | 11 | 35 | 24 pts below |
GIB is trading at 14x earnings, a 48% discount to the Technology sector's median of 28x, though its earnings don't support one.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over GIB on valuation relative to its sector.
GIB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $76.4 | 7.1% above |
| 20 week MA | $73.2 | 12% above |
| 50 week MA | $75.4 | 8.6% above |
| 100 week MA | $88.2 | 7.2% below |
| 200 week MA | $96.2 | 15% below |
GIB has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 15% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
GIB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $84.1 | $79.4 | -5.6% |
| 2021 | $79.4 | $87.3 | +10% |
| 2022 | $87.3 | $85.9 | -1.5% |
| 2023 | $85.9 | $107.2 | +25% |
| 2024 | $107.2 | $109.9 | +2.5% |
| 2025 | $109.9 | $93.8 | -15% |
| 2026 YTD | $93.8 | $81.8 | -13% |
GIB has finished lower in three of the last six years. It's down 13% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over GIB on returns for 2026, with the stronger performance.